EDMONTON, Alberta, Oct. 20 /PRNewswire-FirstCall/ -- Medical Services International Inc. is pleased to announce that the demand for the VScan rapid test kits is increasing. In addition to the orders for the test kits through established distributors and through our existing contracts, Medical Services is being contacted by companies on a daily basis about becoming distributors for Medical Services or just buying the VScan test kits. In the first two weeks in October, 2005, the Company acquired 3 new distributors who placed initial orders for test kits that had a value of $410,000 USD. All orders are being backed by Letters of Credit from Western Banks.
These orders are in addition to orders from existing contracts. The Company is negotiating in different parts of the world with several other companies who wish to become distributors of the VScan products. It is anticipated that based on the initial orders that will be placed by these new distributors combined with the projected second quarter revenues from existing contracts and the orders placed in the first two weeks in October, the projected second quarter revenues will increase from $1,315,000 USD to $2,015,000 USD with an estimated profit of $702,000 USD.
About VScan
The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use test for the screening of HIV1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada.
Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol “MSITF”. For further information, please contact Robert Talbot at (780) 430 6363 or media contact Bill Whitehead at (416) 822 5883 or http://www.medicalservicesintl.com or http://www.minerva-biotech.com .
NOTE: Certain statements in this press release are “forward-looking statements” within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and filings with regulatory bodies.
Medical Services International Inc.
CONTACT: Robert Talbot, +1-780-430-6363, or Bill Whitehead,+1-416-822-5883, for Medical Services International Inc.